查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美轉染試劑和設備市場預測至 2030 年 - 區域分析 - 按產品、方法、應用和最終用戶
市場調查報告書
商品編碼
1562251

北美轉染試劑和設備市場預測至 2030 年 - 區域分析 - 按產品、方法、應用和最終用戶

North America Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 108 Pages | 訂單完成後即時交付

價格

2022年北美轉染試劑和設備市場價值為5.4057億美元，預計2030年將達到9.9553億美元；預計 2022 年至 2030 年複合年成長率為 7.9%。

公司的策略性措施推動北美轉染試劑和設備市場

在北美轉染試劑和設備市場營運的公司專注於策略發展，例如合作、擴張、協議、夥伴關係和新產品發布，這有助於他們提高銷售、擴大地理範圍並增強滿足市場需求的能力。現有的客戶群更大。這些發展也在一定程度上有助於向市場引入新趨勢。以下提到了北美轉染試劑和設備市場的一些值得注意的發展。

2023 年4 月，賽默飛世爾科技推出了Invitrogen Neon NxT 電穿孔系統，即使是最具挑戰性的細胞類型，該系統也能促進轉染，從而實現高效率、細胞回收率和重現性。 Neon NxT 電極經過最佳放置，可提供最小的表面積並產生更均勻的電場，並在轉染過程中保持適當的生理條件，從而使所需的修飾能夠在更多細胞中發生，並減少在此過程中損失的細胞數量。新系統還具有改進的回饋迴路和人體工學增強功能，易於使用。 2021年8月，Mirus Bio推出了TransIT VirusGEN GMP產品線，該產品線提供轉染試劑和增強劑，以支持用於基因療法開發的病毒載體的製造。 TransIT VirusGEN GMP 轉染試劑旨在增強轉移疫苗 DNA 向懸浮細胞和貼壁 HEK 293 細胞的遞送，從而使重組 AAV 和 LV 載體的生產更加高效。 2020 年7 月，Polyplus-transfection SA 為其PEIpro 轉染試劑產品組合推出了首個符合GMP 規定的殘留測試，旨在支持慢病毒和腺相關病毒(AAV) 生產的臨床前、臨床和商業流程的開發細胞和基因療法。此外，Polyplus-transfection 還推出了用於後期和商業化細胞和基因療法的 PEIpro-GMP 產品的雙重採購。因此，推出了轉染試劑和系統等產品；開發針對各種健康問題的創新產品，以創造新的或改進的產品；以及啟動新業務以保持市場競爭力，所有這些透過合作和夥伴關係都可以幫助加快轉染試劑和設備新平台的開發。

北美轉染試劑與設備市場概況

細胞和基因療法（CGT）用於治療嚴重和罕見疾病且治療需求未滿足的患者。製造 CGT 是一個高度複雜的過程，基礎設施和專業知識的不足是一個主要限制。與中間體和最終產品相關的物流相關挑戰也限制了公司的 CGT 製造能力。 CGT的製造過程包括透過「單採術」提取自體細胞，將其送往專門實驗室，然後送回診所給患者施用，所有這些都必須在嚴格的品質控制下進行。迄今為止，美國食品藥物管理局 (FDA) 僅批准了 7 種 CGT 藥物，新產品管線已達到約 1,200 種實驗療法。其中一半正在進行二期臨床試驗。根據《2023 年化學與工程新聞報告》，鑑於這些前景，細胞療法和基因療法的年銷售額預計將分別成長 15% 和 30% 左右。

許多製造商與 Labcorp、Lonza 和 Catalent 等合約開發製造組織 (CDMO) 接洽，以克服與其 CGT 產品生產和商業化相關的障礙。 Lonza 已投資約 920 萬美元來增強其細胞和基因治療製造能力。 CDMO 的此類措施正在促進美國轉染試劑和設備市場的成長。

此外，2022年2月，創新、科學與工業部長Francois-Philippe Champagne宣布透過加拿大創新基金會（CFI）向加拿大政府提供4,500萬美元資金，以確保研究團隊擁有合適的實驗室和基礎設施，以及利用技術部門進行世界一流研究的機會。加拿大衛生研究院 (CIHR) 宣布與魁北克藥物發現聯盟 (CQDM) 建立合作夥伴關係，以開展一項新的個人化醫療合作資助計劃，以加速藥物發現和藥物開發。

北美轉染試劑和設備市場收入及2030年預測（百萬美元）

北美轉染試劑與設備市場細分

北美轉染試劑和設備市場根據產品、方法、應用、最終用戶和國家進行細分。

根據產品，北美轉染試劑和設備市場分為試劑和儀器。 2022 年，試劑細分市場將佔更大佔有率。

從方法來看，北美轉染試劑和設備市場分為病毒方法、非病毒方法和混合方法。 2022 年，非病毒方法部分佔最大佔有率。非病毒部分分為物理/機械方法和化學方法。此外，物理/機械方法細分為電穿孔、顯微注射、生物彈體方法、雷射方法、磁轉染和聲穿孔。此外，化學方法部分又分為基於脂質體/高脂質和基於非脂質體/高脂質。

按應用分類，北美轉染試劑和設備市場分為生物醫學研究、蛋白質生產和治療遞送。 2022 年，生物醫學研究領域佔最大佔有率。

根據最終用戶，北美轉染試劑和設備市場分為學術和研究機構以及製藥和生物技術公司。 2022 年，學術和研究機構領域佔據了更大的佔有率。

依國家分類，北美轉染試劑和設備市場分為美國、加拿大和墨西哥。 2022年，美國主導北美轉染試劑和設備市場。

Thermo Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG、MaxCyte Inc 和 Polyplus-Transfection SA 是一些領先公司經營北美轉染試劑和設備市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美轉染試劑與設備市場 - 主要市場動態

  • 北美轉染試劑和設備市場 - 主要市場動態
  • 市場促進因素
    • 細胞和基因療法越來越受歡迎
    • 癌症帶來的經濟負擔日益沉重
  • 市場限制
    • 儀器及耗材成本高
  • 市場機會
    • 將小規模流程升級為大規模流程
  • 未來趨勢
    • 公司的策略舉措
  • 促進因素和限制的影響：

第 5 章：轉染試劑與設備市場 - 北美市場分析

  • 2022-2030年北美轉染試劑與設備市場收入
  • 北美轉染試劑及設備市場預測分析

第 6 章：北美轉染試劑與設備市場分析 - 按產品

  • 試劑
  • 裝置

第 7 章：北美轉染試劑與設備市場分析 - 依方式

  • 病毒性的
  • 非病毒性
  • 混合

第 8 章：北美轉染試劑與設備市場分析 - 按應用

  • 生物醫學研究
  • 蛋白質生產
  • 治療實施

第 9 章：北美轉染試劑和設備市場分析 - 按最終用戶

  • 學術及研究機構
  • 製藥和生物技術公司

第 10 章：北美轉染試劑與設備市場 - 國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第 11 章：轉染試劑與設備市場 - 產業格局

  • 概述
  • 2020-2023 年轉染試劑和設備市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Polyplus-Transfection SA

第 13 章：附錄

Product Code: BMIRE00030528

The North America transfection reagents and equipment market was valued at US$ 540.57 million in 2022 and is expected to reach US$ 995.53 million by 2030; it is estimated to register at a CAGR of 7.9% from 2022 to 2030.

Strategic Initiatives by Companies Fuel North America Transfection Reagents and Equipment Market

Companies operating in the North America transfection reagents and equipment market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic scope, and enhance their capacities to cater to a larger than existing customer base. These developments also contribute to the introduction of new trends to the market to a certain extent. A few of the noteworthy developments in the North America transfection reagents and equipment market are mentioned below.

In April 2023, Thermo Fisher Scientific launched the Invitrogen Neon NxT Electroporation System that facilitates transfection, even with the most challenging cell types, enabling high efficiency, cell recovery, and reproducibility. Neon NxT electrodes are optimally placed to provide minimal surface area and create a more uniform electric field, and maintain apt physiological conditions during transfection, thereby enabling the desired modification to take place in more cells and reducing the number of cells lost during the process. The new system also features an improved feedback loop and ergonomic enhancements for ease of use. In August 2021, Mirus Bio launched the TransIT VirusGEN GMP Product Line, which provides transfection reagents and enhancers to support the manufacturing of viral vectors for the development of gene therapies. The TransIT VirusGEN GMP transfection reagent was developed to enhance the delivery of transfer vaccine DNA to suspension and adherent HEK 293 cells to make the production of recombinant AAV and LV vectors more efficient. In July 2020, Polyplus-transfection SA launched the first GMP-compliant residual test for its PEIpro product portfolio of transfection reagents designed to support the development of the preclinical, clinical, and commercial process of lentivirus and adeno-associated virus (AAV) production for cell and gene therapies. In addition, Polyplus-transfection also launched dual sourcing for its PEIpro-GMP product for late-stage and commercialization cell and gene therapies. Thus, the introduction of products such as transfection reagents and systems; the development of innovative products targeting various health issues to create new or improved products; and the initiation of new businesses to remain competitive in the market, all, through collaborations and partnerships can help speed up the development of new platforms for transfection reagents and equipment.

North America Transfection Reagents and Equipment Market Overview

Cell and gene therapies (CGTs) are prescribed to treat patients suffering from serious and rare diseases with unaddressed therapeutic needs. Manufacturing CGTs is a highly complex process, with the insufficiency of infrastructure and expertise being a major limiting factor. Logistics-related challenges associated with intermediates and the final product also limit the CGT manufacturing capacity of companies. The CGT manufacturing process involves the extraction of autologous cells through "apheresis," dispatching them to specialized laboratories and sending them back to clinics for administration into patients, all of which must be performed with strict quality control. The US Food and Drug Administration (FDA) has approved only 7 CGT drugs so far, and the pipeline of new products has reached ~1,200 experimental therapies. Half of these are in Phase 2 clinical trials. With these prospects, annual sales of cell therapies and gene therapies are estimated to grow by 15% and ~30%, respectively, as stated in the Chemical & Engineering News Report 2023.

Many manufacturers approach contract development manufacturing organizations (CDMOs) such as Labcorp, Lonza, and Catalent to overcome the barriers associated with the production and commercialization of their CGT products. Lonza has invested ~US$ 9.2 million to strengthen its cell and gene therapy manufacturing capabilities. Such initiatives by CDMOs are contributing to the growth of the transfection reagents and equipment market in the US.

Furthermore, in February 2022, Francois-Philippe Champagne, the minister of Innovation, Science and Industry, announced the funding of US$ 45 million to the Government of Canada through the Canada Foundation for Innovation (CFI) to ensure that research teams have appropriate labs and infrastructure, and access to technology departments for carrying about world-class research. The Canadian Institutes of Health Research (CIHR) announced a partnership with the Quebec Consortium for Drug Discovery (CQDM) for a new collaborative funding program on personalized medicine to accelerate drug discovery and drug development.

North America Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)

North America Transfection Reagents and Equipment Market Segmentation

The North America transfection reagents and equipment market is segmented based on product, method, application, end user, and country.

Based on product, the North America transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.

In terms of method, the North America transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is sub categorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is sub categorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is sub categorized into liposomal based/high lipid and non-liposomal/high lipid based.

By application, the North America transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.

Based on end user, the North America transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.

Based on country, the North America transfection reagents and equipment market is categorized into the US, Canada, and Mexico. The US dominated the North America transfection reagents and equipment market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc, and Polyplus-Transfection SA are some of the leading companies operating in the North America transfection reagents and equipment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Transfection Reagents and Equipment Market - Key Market Dynamics

  • 4.1 North America Transfection Reagents and Equipment Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Popularity of Cell and Gene Therapy
    • 4.2.2 Growing Economic Burden of Cancer
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments and Consumables
  • 4.4 Market Opportunities
    • 4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
  • 4.5 Future Trends
    • 4.5.1 Strategic Initiatives by Companies
  • 4.6 Impact of Drivers and Restraints:

5. Transfection Reagents and Equipment Market - North America Market Analysis

  • 5.1 North America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • 5.2 North America Transfection Reagents and Equipment Market Forecast Analysis

6. North America Transfection Reagents and Equipment Market Analysis - by Product

  • 6.1 Reagents
    • 6.1.1 Overview
    • 6.1.2 Reagents: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Equipment
    • 6.2.1 Overview
    • 6.2.2 Equipment: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Transfection Reagents and Equipment Market Analysis - by Modality

  • 7.1 Viral
    • 7.1.1 Overview
    • 7.1.2 Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.1 Retrovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.2 Adenovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.3 Adeno-Associated Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.4 Herpes Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Non-Viral
    • 7.2.1 Overview
    • 7.2.2 Non-Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.1 Physical/Mechanical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.1 Electroporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.2 Microinjection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.3 Biolistic Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.4 Laser Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.5 Magnetofection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.6 Sonoporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.2 Chemical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.1 Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.2 Non-Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Hybrid
    • 7.3.1 Overview
    • 7.3.2 Hybrid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Transfection Reagents and Equipment Market Analysis - by Application

  • 8.1 Biomedical Research
    • 8.1.1 Overview
    • 8.1.2 Biomedical Research: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Protein Production
    • 8.2.1 Overview
    • 8.2.2 Protein Production: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Therapeutic Delivery
    • 8.3.1 Overview
    • 8.3.2 Therapeutic Delivery: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Transfection Reagents and Equipment Market Analysis - by End Users

  • 9.1 Academic and Research Institutes
    • 9.1.1 Overview
    • 9.1.2 Academic and Research Institutes: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Pharmaceutical and Biotechnological Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biotechnological Companies: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Transfection Reagents and Equipment Market -Country Analysis

  • 10.1 North America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
    • 10.1.1 North America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 United States: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.1.2 United States: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.1.2.1 United States: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.1.2.2 United States: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.1.2.2.1 United States: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.1.2.2.2 United States: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.1.3 United States: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.1.4 United States: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.1.2 Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.2.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.2.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.2.2.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.2.2.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.2.3 Canada: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.2.4 Canada: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.1.3 Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.3.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.3.2.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.3.2.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.3.2.2.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.3.2.2.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.3.3 Mexico: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.3.4 Mexico: Transfection Reagents and Equipment Market Breakdown, by End Users

11. Transfection Reagents and Equipment Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. Hoffmann-La Roche Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Bio-Rad Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Mirus Bio LLC
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 QIAGEN NV
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Merck KGaA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Lonza Group AG
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 MaxCyte Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Polyplus-Transfection SA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us

List Of Tables

  • Table 1. North America Transfection Reagents and Equipment Market Segmentation
  • Table 2. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
  • Table 5. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
  • Table 6. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
  • Table 7. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
  • Table 8. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
  • Table 9. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 10. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
  • Table 11. North America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 12. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 13. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 14. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 15. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 16. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 17. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 18. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 20. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 21. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 22. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 23. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 24. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 25. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 26. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 27. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 28. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 30. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 31. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 32. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 33. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 34. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 35. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 36. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
  • Table 37. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

List Of Figures

  • Figure 1. North America Transfection Reagents and Equipment Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. North America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • Figure 4. North America Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
  • Figure 5. Reagents: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 6. Equipment: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. North America Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
  • Figure 8. Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Retrovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Adenovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Adeno-Associated Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Herpes Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Non-Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Physical/Mechanical: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Electroporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Microinjection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Biolistic Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Laser Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Magnetofection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Sonoporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Chemical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Non-Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Hybrid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
  • Figure 26. Biomedical Research: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Protein Production: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Therapeutic Delivery: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. North America Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
  • Figure 30. Academic and Research Institutes: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pharmaceutical and Biotechnological Companies: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. North America: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
  • Figure 33. North America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 34. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023